Drug Chatter -- Tracking biopharma stock chatter

Profile for Arrowhead Research Corporation (ARWR)

« Back to company index

ARWR Chatter Timeline

Stock Ticker for ARWR

Most Active Tweeters for ARWR

UserTweets
@truthtracer 6
@noritsunagirota 5
@Thinknwaves 5
@WeekHerald 3
@yuhuuuuuuiui 2

Recent Tweets for ARWR

tanavoi373 @tanavoi373
$ARWR piper jaffray fireside chat is only 1 week away. i expect a runup into it and possibly after.
November 20th 2017, 11:11am
noritsunagirota @noritsunagirota
$-0.13 EPS Expected for Arrowhead Pharmaceuticals $ARWR https://t.co/8JPc5j3Mka
November 20th 2017, 6:11am
Thinknwaves @Thinknwaves
RT @truthtracer: Astonishing misdiagnosis level~As $ARWR ARO-AAT progresses through clinic the publicity will surely enlighten. https://t.c…
November 20th 2017, 1:11am
chaffeybreeze @chaffeybreeze
Arrowhead Pharmaceuticals $ARWR Receives Daily Media Sentiment Rating of 0.17 https://t.co/rFRnTISfuX
November 19th 2017, 12:11pm
IRAMarketReport @IRAMarketReport
Arrowhead Pharmaceuticals $ARWR Receives Daily Media Sentiment Rating of 0.17 https://t.co/171A247YqN
November 19th 2017, 11:11am
ByrdTrading79 @ByrdTrading79
has anyone else tried this? i've been getting in on some amazing trades through it https://t.co/ti6dlFeH6m $ARWR… https://t.co/6U4Akh2s8C
November 17th 2017, 9:11pm
DmdMt24 @DmdMt24
$Alny buying $ARWR...
November 17th 2017, 1:11pm
nelsnyc @nelsnyc
Waiting on $ARWR, to make a comeback....
November 17th 2017, 11:11am
clayton_dd @clayton_dd
ARWR 3.83 Arrowhead Pharma $ARWR Std Dev +1.88. ARWR Trading at 3.83 Day High 3.87 & Day Low 3.62 Change +0.24 https://t.co/1N0f5ZRNrj
November 17th 2017, 11:11am
noritsunagirota @noritsunagirota
Arrowhead Pharmaceuticals $ARWR Reaches $3.80 After 5.00% Up Move https://t.co/DXT6IH0yoZ
November 17th 2017, 11:11am
nelsnyc @nelsnyc
Looks ready $ARWR
November 17th 2017, 10:11am
truthtracer @truthtracer
@SauveRod @joey_pots Here is a link that I have found helpful regarding new $ARWR patents. It helps to keep you con… https://t.co/rj83hTfSNW
November 16th 2017, 10:11pm
truthtracer @truthtracer
@SauveRod @joey_pots It’s fairly compelling to observe $ARWR ‘s issued patents. They’re moving closer to proof of c… https://t.co/eedtFp1VJp
November 16th 2017, 9:11pm
engrcat @engrcat
RT @truthtracer: $ARWR taking a run at Cystic Fibrosis (4th paragraph down) latest filed patent. Swinging for the fences, aggressive… https…
November 16th 2017, 8:11pm
truthtracer @truthtracer
$ARWR taking a run at Cystic Fibrosis (4th paragraph down) latest filed patent. Swinging for the fences, aggressive… https://t.co/rDYZ0COTyZ
November 16th 2017, 5:11pm
digdeeper1976 @digdeeper1976
@RNAiAnalyst Still holding $ARWR? The AD “Skittles” presentation impressed you? No clinical data until Q4 18 and th… https://t.co/fPesywwe9D
November 16th 2017, 7:11am
surveyist @surveyist
RT @RNAiAnalyst: $ARWR is still my largest position...just waiting to see whether they're executing on getting into clinic. Consider $AMGN…
November 15th 2017, 7:11pm
GMHikaru @GMHikaru
@joey_pots @RNAiAnalyst I prefer $DRNA, although I hold some $ARWR as well.
November 15th 2017, 5:11pm
RNAiAnalyst @RNAiAnalyst
$ARWR is still my largest position...just waiting to see whether they're executing on getting into clinic. Consider $AMGN free upside.
November 15th 2017, 5:11pm
DrFidelCashflow @DrFidelCashflow
$ARWR Did some buying earlier https://t.co/h0OzWdMwry
November 15th 2017, 4:11pm
stocknewstimes @stocknewstimes
Contrasting Arrowhead Pharmaceuticals $ARWR and Its Peers https://t.co/6D4THFORTF
November 15th 2017, 12:11pm
noritsunagirota @noritsunagirota
Arrowhead Pharmaceuticals $ARWR Analysts See $-0.13 EPS https://t.co/320pboYHwx
November 15th 2017, 8:11am
WeekHerald @WeekHerald
Contrasting Arrowhead Pharmaceuticals $ARWR & The Competition https://t.co/KumbwvY6LX
November 15th 2017, 5:11am
Thinknwaves @Thinknwaves
@truthtracer Nice disclosure. $ARWR
November 14th 2017, 9:11pm
Thinknwaves @Thinknwaves
@truthtracer $ARWR Finally, we get some data referencing what went wrong w CALAA-1 cytokine/chemokine signals revealed = "*TLR Activation?"
November 14th 2017, 9:11pm
Thinknwaves @Thinknwaves
RT @truthtracer: Synopsis by $ARWR Chief Scientific Officer, Bruce Givens. What took RNAi so long?~The delivery saga. https://t.co/Xtci8Ba…
November 14th 2017, 9:11pm
Thinknwaves @Thinknwaves
@RNAiAnalyst Is $SLN gaining some of $ARWR 'masking-chemistry' techniques?
November 14th 2017, 9:11pm
MomoTrader007 @MomoTrader007
$ARWR should be next on line headed for $2 or lower -- still same old tricks played by management to lure new retail buyers
November 14th 2017, 1:11pm
truthtracer @truthtracer
@hedgiehedgerton @RNAiAnalyst Would be interesting to know if CEO Anzalone has ever given serious thought to $ARWR… https://t.co/2y2nISJvc4
November 14th 2017, 11:11am
truthtracer @truthtracer
This, along with some history. Gives one some footing with regards to RNAi in general. Just scroll down. $ARWR
November 14th 2017, 10:11am
truthtracer @truthtracer
Synopsis by $ARWR Chief Scientific Officer, Bruce Givens. What took RNAi so long?~The delivery saga. https://t.co/Xtci8Baz7H
November 14th 2017, 10:11am
catalystinvstor @catalystinvstor
Arrowhead $ARWR to Present at 29th Annual Piper Jaffray Healthcare Conference On Nov. 28 https://t.co/rlaWEfPIOK
November 14th 2017, 8:11am
stockboardinc @stockboardinc
$ARWR Arrowhead to Present at 29th Annual Piper Jaffray Healthcare Conference... - https://t.co/SUykkeLK0P
November 14th 2017, 7:11am
newswithvalue @newswithvalue
$ARWR: Arrowhead to Present at 29th Annual Piper Jaffray Healthcare …: https://t.co/nQNw71MoKz
November 14th 2017, 7:11am
Pandajigu @Pandajigu
$ARWR setting up for a nice break around 3.80, MV cross, rising wedge. setting alert and moving on. me likey
November 14th 2017, 12:11am
TranscriptDaily @TranscriptDaily
Somewhat Positive Press Coverage Somewhat Unlikely to Affect Arrowhead Pharmaceuticals $ARWR Share Price https://t.co/dE7hCLoblX
November 13th 2017, 10:11pm
yuhuuuuuuiui @yuhuuuuuuiui
true or false, $alny buying $arwr for its superior technology?
November 13th 2017, 3:11pm
noritsunagirota @noritsunagirota
Analysts See $-0.13 EPS for Arrowhead Pharmaceuticals $ARWR https://t.co/5dWeTZskiT
November 13th 2017, 8:11am
WeekHerald @WeekHerald
Head to Head Survey: Arrowhead Pharmaceuticals $ARWR & Sarepta Therapeutics $SRPT https://t.co/XSmIOXYB5Q
November 13th 2017, 5:11am
noritsunagirota @noritsunagirota
Arrowhead Pharmaceuticals $ARWR Analysts See $-0.13 EPS https://t.co/kMA4xpDdSd
November 12th 2017, 7:11am
AmericanBanking @AmericanBanking
Arrowhead Pharmaceuticals, Inc. $ARWR Expected to Announce Quarterly Sales of $7.32 Million https://t.co/rg5Nc7Denk
November 11th 2017, 10:11am
CFinancialNews @CFinancialNews
Arrowhead Pharmaceuticals, Inc. $ARWR Expected to Announce Quarterly Sales of $7.32 Million https://t.co/3wvN6woRiT
November 11th 2017, 10:11am
intercooleronli @intercooleronli
Arrowhead Pharmaceuticals, Inc. $ARWR Expected to Announce Quarterly Sales of $7.32 Million https://t.co/1lO1k2JHjI
November 11th 2017, 10:11am
storminvestor @storminvestor
Arrowhead Pharmaceuticals, Inc. $ARWR Expected to Announce Quarterly Sales of $7.32 Million https://t.co/8zztrlG5Hd
November 11th 2017, 10:11am
ConsumerFeed @ConsumerFeed
Arrowhead Pharmaceuticals, Inc. $ARWR Expected to Announce Quarterly Sales of $7.32 Million https://t.co/mzZF2MDZFa #acn
November 11th 2017, 10:11am
SPNewsAnalysis @SPNewsAnalysis
Arrowhead Pharmaceuticals, Inc. $ARWR Expected to Announce Quarterly Sales of $7.32 Million https://t.co/5zAO52RaP3
November 11th 2017, 10:11am
dispatchtribune @dispatchtribune
Arrowhead Pharmaceuticals $ARWR & Its Competitors Critical Contrast https://t.co/FoZVnKxiRC
November 11th 2017, 7:11am
dailypoliticaln @dailypoliticaln
Arrowhead Pharmaceuticals, Inc. $ARWR Position Decreased by Schwab Charles Investment Management Inc. https://t.co/HsjEOedX2v
November 11th 2017, 4:11am
midetimes @midetimes
Arrowhead Pharmaceuticals, Inc. $ARWR Position Decreased by Schwab Charles Investment Management Inc. https://t.co/2T410eARrs
November 11th 2017, 4:11am
dailymailtimes @dailymailtimes
Arrowhead Pharmaceuticals, Inc. $ARWR Position Decreased by Schwab Charles Investment Management Inc. https://t.co/qF1YOQyzBx
November 11th 2017, 4:11am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.